Patriot Investment Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$983K Sell
3,906
-776
-17% -$167K 0.06% 123
2026
Q1
$1.02M Buy
4,682
+5
+0.1% +$1.11K 0.07% 115
2025
Q4
$1.07M Sell
4,677
-602
-11% -$137K 0.07% 109
2025
Q3
$1.22M Sell
5,279
-6
-0.1% -$1.22K 0.08% 104
2025
Q2
$981K Buy
5,285
+17
+0.3% +$3.16K 0.07% 109
2025
Q1
$1.1M Buy
5,268
+5
+0.1% +$972 0.08% 102
2024
Q4
$935K Sell
5,263
-123
-2% -$22.6K 0.07% 110
2024
Q3
$1.06M Sell
5,386
-535
-9% -$99.8K 0.08% 109
2024
Q2
$1.02M Buy
5,921
+5
+0.1% +$828 0.08% 106
2024
Q1
$1.08M Buy
5,916
+1,915
+48% +$330K 0.09% 104
2023
Q4
$620K Sell
4,001
-525
-12% -$76.5K 0.05% 142
2023
Q3
$675K Sell
4,526
-1,112
-20% -$163K 0.06% 127
2023
Q2
$760K Sell
5,638
-39
-0.7% -$5.72K 0.06% 129
2023
Q1
$905K Buy
5,677
+276
+5% +$42.2K 0.08% 115
2022
Q4
$790K Sell
5,401
-56
-1% -$8.59K 0.07% 124
2022
Q3
$732K Sell
5,457
-314
-5% -$45.1K 0.08% 123
2022
Q2
$883K Sell
5,771
-208
-3% -$31.8K 0.09% 111
2022
Q1
$969K Buy
5,979
+596
+11% +$86.6K 0.08% 115
2021
Q4
$728K Buy
5,383
+559
+12% +$66K 0.06% 142
2021
Q3
$520K Buy
4,824
+258
+6% +$29.5K 0.05% 169
2021
Q2
$514K Buy
4,566
+268
+6% +$30.2K 0.05% 165
2021
Q1
$465K Buy
+4,298
New +$460K 0.05% 166
2020
Q4
Sell
-3,698
Closed -$323K 174
2020
Q3
$323K Buy
3,698
+66
+2% +$6.21K 0.04% 177
2020
Q2
$357K Buy
3,632
+268
+8% +$23.6K 0.05% 170
2020
Q1
$256K Sell
3,364
-2,548
-43% -$217K 0.04% 180
2019
Q4
$523K Hold
5,912
0.07% 144
2019
Q3
$440K Sell
5,912
-300
-5% -$20.6K 0.06% 154
2019
Q2
$451K Buy
6,212
+300
+5% +$23.6K 0.06% 154
2019
Q1
$476K Buy
+5,912
New +$484K 0.07% 147

Other funds holding ABBV

Patriot Investment Management Group's ABBV Position: Q2 2026 in Review

Patriot Investment Management Group reduced its AbbVie (ABBV) stake by 17% in Q2 2026, selling an estimated $167K and leaving 3,906 shares worth $983K. The position accounts for 0.06% of the portfolio, ranked #123.

Patriot Investment Management Group first reported a position in ABBV in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.22M in Q3 2025. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Patriot Investment Management Group held 3,906 shares of AbbVie worth $983K as of Q2 2026.
  • Patriot Investment Management Group sold 776 AbbVie shares in Q2 2026, an estimated $167K.
  • AbbVie made up 0.06% of Patriot Investment Management Group's portfolio in Q2 2026, its #123 holding.
  • Patriot Investment Management Group first reported a position in AbbVie in Q1 2019 and has held it in 29 quarters since.
  • Patriot Investment Management Group's AbbVie position peaked at $1.22M in Q3 2025.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Patriot Investment Management Group's 13F filing for Q2 2026, filed 15 Jul 2026.